Leidos awarded a $318 million sole‑source contract to support the MHS GENESIS health‑record system
Leidos Holdings Inc. announced a bridge contract with the Defense Health Agency to provide system reintegration, software licensing and hosting for the MHS GENESIS electronic health‑record platform. The contract is valued at $317.99 million and runs through January 2028, funded from the FY2026 operations and maintenance budget. The award extends Leidos’ role as a primary IT services provider for U.S. defense health operations.
Why it matters
The contract adds several years of guaranteed revenue from a core government client, enhancing Leidos’ cash‑flow visibility. The funding from FY2026 ensures the deal will be reflected in the company’s near‑term financial results.
Key facts
- 1Leidos was awarded a sole‑source bridge contract valued at $317.99 million. gurufocus.com
- 2The contract covers system reintegration, software licensing and hosting services for MHS GENESIS. gurufocus.com
- 3The agreement runs through January 2028. gurufocus.com
- 4Funding is allocated from the fiscal year 2026 operations and maintenance budget. gurufocus.com
- 5Insiders have sold $3.2 million of Leidos shares over the past 12 months. gurufocus.com
- 6Leidos received a GF Score™ of 85 out of 100. gurufocus.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.